Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lemoine, FM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-18 z 18
    Tytuł:
    Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells
    Autorzy:
    Yao, MingAff1, Aff2
    Fouillard, L
    Lemoine, FM
    Bouchet, S
    Firat, H
    Andreu, G
    Gorin, NC
    Douay, LAff4, Aff6
    Lopez, MAff1, Aff2
    Pokaż więcej
    Źródło:
    Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 26(5):497-503
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Publisher Correction: A first experience of transduction for differentiated HepaRG cells using lentiviral technology.
    Autorzy:
    Pivert A; Laboratory of Virology, University Hospital & LUNAM University and HIFIH Laboratory, UPRES EA 3859, SFR 4208, Angers, France. .
    Lefeuvre C; Laboratory of Virology, University Hospital & LUNAM University and HIFIH Laboratory, UPRES EA 3859, SFR 4208, Angers, France.
    Tran CT; Laboratory of Virology, University Hospital & LUNAM University and HIFIH Laboratory, UPRES EA 3859, SFR 4208, Angers, France.
    Baillou C; Sorbonne Université, Inserm, CNRS, Centre d'Immunologie et Maladies Infectieuses (CIMI-Paris), Paris, France.
    Durantel D; Cancer Research Center of Lyon (CRCL), INSERM, U1052, CNRS, University of Lyon, UMR_5286, LabEx DEVweCAN, Lyon, France.
    Le Guillou-Guillemette H; Laboratory of Virology, University Hospital & LUNAM University and HIFIH Laboratory, UPRES EA 3859, SFR 4208, Angers, France.
    Lemoine FM; Sorbonne Université, Inserm, CNRS, Centre d'Immunologie et Maladies Infectieuses (CIMI-Paris), Paris, France.
    Lunel-Fabiani F; Laboratory of Virology, University Hospital & LUNAM University and HIFIH Laboratory, UPRES EA 3859, SFR 4208, Angers, France.
    Ducancelle A; Laboratory of Virology, University Hospital & LUNAM University and HIFIH Laboratory, UPRES EA 3859, SFR 4208, Angers, France.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2021 Sep 06; Vol. 11 (1), pp. 18051. Date of Electronic Publication: 2021 Sep 06.
    Typ publikacji:
    Published Erratum
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Cigarette smoking induces human CCR6 Th17 lymphocytes senescence and VEGF-A secretion.
    Autorzy:
    Baskara I; Université Paris-Est, Créteil, 94000, France.; Inserm, UMR 955, équipe 4, Créteil, F-94010, France.
    Kerbrat S; Université Paris-Est, Créteil, 94000, France.; Inserm, UMR 955, équipe 4, Créteil, F-94010, France.
    Dagouassat M; Université Paris-Est, Créteil, 94000, France.; Inserm, UMR 955, équipe 4, Créteil, F-94010, France.
    Nguyen HQ; Université Paris-Est, Créteil, 94000, France.; Inserm, UMR 955, équipe 7, Créteil, F-94010, France.
    Guillot-Delost M; Institut Curie, PSL Research University, Paris, France.; Inserm, UMR 932, F-75005, Paris, France.
    Surenaud M; Inserm, UMR 955, équipe 16, Créteil, 94000, France.
    Baillou C; Sorbonne Université, UPMC Univ-Paris 06, CIMI-Paris- INSERM UMR U 1135, Paris, France.
    Lemoine FM; Sorbonne Université, UPMC Univ-Paris 06, CIMI-Paris- INSERM UMR U 1135, Paris, France.
    Morin D; Université Paris-Est, Créteil, 94000, France.; Inserm, UMR 955, équipe 3, Créteil, F-94010, France.
    Boczkowski J; Université Paris-Est, Créteil, 94000, France.; Inserm, UMR 955, équipe 4, Créteil, F-94010, France.
    Le Gouvello S; Université Paris-Est, Créteil, 94000, France. .; Inserm, UMR 955, équipe 4, Créteil, F-94010, France. .; AP-HP, Hôpital H. Mondor- A. Chenevier, Pôle de Biologie-Pathologie, Créteil, 94000, France. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Apr 16; Vol. 10 (1), pp. 6488. Date of Electronic Publication: 2020 Apr 16.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cellular Senescence/*immunology
    Cigarette Smoking/*immunology
    Th17 Cells/*immunology
    Vascular Endothelial Growth Factor A/*metabolism
    Blood Buffy Coat/cytology ; Cells, Cultured ; Cellular Senescence/drug effects ; Cigarette Smoking/adverse effects ; Cigarette Smoking/blood ; Cytokines/metabolism ; Healthy Volunteers ; Humans ; MAP Kinase Signaling System/immunology ; Oxidative Stress/drug effects ; Oxidative Stress/immunology ; Primary Cell Culture ; Reactive Oxygen Species/metabolism ; Receptors, CCR6/metabolism ; Smoke/adverse effects ; T-Lymphocytes, Regulatory/immunology ; T-Lymphocytes, Regulatory/metabolism ; Th17 Cells/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A first experience of transduction for differentiated HepaRG cells using lentiviral technology.
    Autorzy:
    Pivert A; Laboratory of Virology, University Hospital & LUNAM University and HIFIH laboratory, UPRES EA 3859, SFR 4208, Angers, France. .
    Lefeuvre C; Laboratory of Virology, University Hospital & LUNAM University and HIFIH laboratory, UPRES EA 3859, SFR 4208, Angers, France.
    Tran CT; Laboratory of Virology, University Hospital & LUNAM University and HIFIH laboratory, UPRES EA 3859, SFR 4208, Angers, France.
    Baillou C; Sorbonne Université, Inserm, CNRS, Centre d'Immunologie et Maladies Infectieuses (CIMI-Paris), Paris, France.
    Durantel D; Cancer Research Center of Lyon (CRCL), INSERM, U1052, CNRS, University of Lyon, UMR_5286, LabEx DEVweCAN, Lyon, France.
    Le Guillou-Guillemette H; Laboratory of Virology, University Hospital & LUNAM University and HIFIH laboratory, UPRES EA 3859, SFR 4208, Angers, France.
    Lemoine FM; Sorbonne Université, Inserm, CNRS, Centre d'Immunologie et Maladies Infectieuses (CIMI-Paris), Paris, France.
    Lunel-Fabiani F; Laboratory of Virology, University Hospital & LUNAM University and HIFIH laboratory, UPRES EA 3859, SFR 4208, Angers, France.
    Ducancelle A; Laboratory of Virology, University Hospital & LUNAM University and HIFIH laboratory, UPRES EA 3859, SFR 4208, Angers, France.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2019 Sep 09; Vol. 9 (1), pp. 12910. Date of Electronic Publication: 2019 Sep 09.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Genetic Vectors*/genetics
    Lentivirus*/genetics
    Transduction, Genetic*
    Hepatocytes/*metabolism
    Animals ; Cell Culture Techniques ; Cell Line ; Flow Cytometry ; Gene Expression ; Genes, Reporter ; Genetic Engineering ; Mice ; Transgenes
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.
    Autorzy:
    Hulot JS; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Salem JE; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Redheuil A; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Collet JP; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Varnous S; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Jourdain P; Centre Hospitalier Pontoise, France.
    Logeart D; UMR-S 942, Université Paris Diderot, DHU FIRE, Department of Cardiology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
    Gandjbakhch E; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Bernard C; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, Clinical Investigation Center for Biotherapies and Inflammation-Immunopathology-Biotherapy Department, F-75013, Paris, France.
    Hatem SN; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Isnard R; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Cluzel P; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Le Feuvre C; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Leprince P; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Hammoudi N; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Lemoine FM; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, Clinical Investigation Center for Biotherapies and Inflammation-Immunopathology-Biotherapy Department, F-75013, Paris, France.
    Klatzmann D; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, Clinical Investigation Center for Biotherapies and Inflammation-Immunopathology-Biotherapy Department, F-75013, Paris, France.
    Vicaut E; ACTION Study Group, Unité de Recherche Clinique, Lariboisière, Paris, France.
    Komajda M; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Montalescot G; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.; ACTION Study Group, Unité de Recherche Clinique, Lariboisière, Paris, France.
    Lompré AM; Sorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC Paris-Est 1421, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, F-75013, Paris, France.
    Hajjar RJ; Cardiovascular Research Center, Icahn School of Medicine at Mount Sinaï, New York, NY, USA.
    Pokaż więcej
    Corporate Authors:
    AGENT-HF Investigators
    Źródło:
    European journal of heart failure [Eur J Heart Fail] 2017 Nov; Vol. 19 (11), pp. 1534-1541. Date of Electronic Publication: 2017 Apr 10.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genetic Therapy/*methods
    Heart Failure, Systolic/*drug therapy
    Sarcoplasmic Reticulum Calcium-Transporting ATPases/*administration & dosage
    Ventricular Remodeling/*physiology
    Aged ; Coronary Vessels ; Double-Blind Method ; Female ; Heart Failure, Systolic/diagnosis ; Heart Failure, Systolic/physiopathology ; Humans ; Infusions, Intra-Arterial ; Male ; Middle Aged ; Treatment Outcome ; Ventricular Remodeling/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study.
    Autorzy:
    Maury S; 1] AP-HP, Hôpital Henri Mondor, Department of Hematology, DHU Virus-Immunity-Cancer, Créteil, France [2] IMRB, University Paris Est Créteil (UPEC), INSERM U955 team 21, Créteil, France [3] Center for Clinical Investigation in Biotherapy, Créteil, France.
    Rosenzwajg M; 1] AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy Department, Paris, France [2] AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center in Biotherapy (CIC-BTi), Paris, France [3] AP-HP, Hôpital Pitié-Salpêtrière, Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France [4] Sorbonne Université, UPMC Univ Paris 06, UMRS 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France [5] INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France.
    Redjoul R; AP-HP, Hôpital Henri Mondor, Department of Hematology, DHU Virus-Immunity-Cancer, Créteil, France.
    Marcais A; Department of Hematology, Hôpital Necker, Paris, France.
    Xhaard A; Department of Hematology-Transplantation, Hôpital St Louis, Paris, France.
    Cherai M; 1] AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy Department, Paris, France [2] AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center in Biotherapy (CIC-BTi), Paris, France.
    Cabanne L; AP-HP, Hôpital Henri Mondor, Department of Hematology, DHU Virus-Immunity-Cancer, Créteil, France.
    Churlaud G; AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy Department, Paris, France.
    Suarez F; Department of Hematology, Hôpital Necker, Paris, France.
    Socié G; Department of Hematology-Transplantation, Hôpital St Louis, Paris, France.
    Gregoire L; Department of Public Health, Créteil, France.
    Debbache K; AP-HP, Hôpital Henri Mondor, Department of Hematology, DHU Virus-Immunity-Cancer, Créteil, France.
    Bernard C; 1] AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy Department, Paris, France [2] AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center in Biotherapy (CIC-BTi), Paris, France [3] AP-HP, Hôpital Pitié-Salpêtrière, Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France.
    Beaumont JL; Department of Hemapheresis, Etablissement Français du Sang, Créteil, France.
    Azar N; AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy Department, Paris, France.
    Boyer O; Sorbonne Universités, UPMC Univ Paris 06, UMR-S INSERM 1135, CIMI-Paris, Paris, France.
    Roudot-Thoraval F; 1] IMRB, University Paris Est Créteil (UPEC), INSERM U955 team 21, Créteil, France [2] Department of Public Health, Créteil, France.
    Cohen JL; 1] IMRB, University Paris Est Créteil (UPEC), INSERM U955 team 21, Créteil, France [2] Center for Clinical Investigation in Biotherapy, Créteil, France.
    Cordonnier C; 1] AP-HP, Hôpital Henri Mondor, Department of Hematology, DHU Virus-Immunity-Cancer, Créteil, France [2] IMRB, University Paris Est Créteil (UPEC), INSERM U955 team 21, Créteil, France.
    Lemoine FM; 1] AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy Department, Paris, France [2] AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center in Biotherapy (CIC-BTi), Paris, France [3] Sorbonne Universités, UPMC Univ Paris 06, UMR-S INSERM 1135, CIMI-Paris, Paris, France.
    Klatzmann D; 1] AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy Department, Paris, France [2] AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center in Biotherapy (CIC-BTi), Paris, France [3] AP-HP, Hôpital Pitié-Salpêtrière, Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France [4] Sorbonne Université, UPMC Univ Paris 06, UMRS 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France [5] INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France.
    Pokaż więcej
    Źródło:
    Leukemia [Leukemia] 2014 Dec; Vol. 28 (12), pp. 2406-10. Date of Electronic Publication: 2014 Aug 08.
    Typ publikacji:
    Clinical Trial, Phase I; Clinical Trial, Phase II; Letter
    MeSH Terms:
    Genes, Transgenic, Suicide*
    Genetic Therapy*
    Immunotherapy, Adoptive*/adverse effects
    Lymphocytes/*metabolism
    Neoplasms/*genetics
    Neoplasms/*therapy
    Graft vs Host Disease/etiology ; Humans ; Lymphocyte Depletion ; Lymphocytes/immunology ; Neoplasms/complications ; Neoplasms/immunology ; Tissue Donors ; Transduction, Genetic ; Treatment Outcome
    Raport
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Bcl-2 and immunoglobulin gene rearrangements in patients with malaria related chronic splenomegaly.
    Autorzy:
    Dascalescu CM; Centre Hospitalier Universitaire Saint-Antoine, 184 rue du Faubourg St. Antoine, 75571 Paris cedex 12, France.
    Rosenzwajg M
    Bonte H
    Mir IA
    Aoudjhane M
    Smadja NV
    Lemoine FM
    Najman A
    Pokaż więcej
    Źródło:
    Leukemia & lymphoma [Leuk Lymphoma] 2004 Oct; Vol. 45 (10), pp. 2093-7.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Genes, Immunoglobulin/*genetics
    Lymphoma/*diagnosis
    Malaria/*complications
    Proto-Oncogene Proteins c-bcl-2/*genetics
    Splenomegaly/*genetics
    Splenomegaly/*parasitology
    Aged ; B-Lymphocytes ; Chronic Disease ; Female ; Gene Rearrangement ; Humans ; Immunoglobulin Heavy Chains/genetics ; Immunophenotyping ; Lymphoma/genetics ; Lymphoma/parasitology ; Male ; Middle Aged ; Splenic Neoplasms/diagnosis ; Splenic Neoplasms/genetics ; Splenic Neoplasms/parasitology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-18 z 18

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies